Fund Sues For Biotech Royalty Biz Books To Aid Proxy Fight
Activist hedge fund Sarissa Capital hit biotech licensing firm Innoviva with a suit in Delaware's Chancery Court on Tuesday, accusing the company's management of cashing out at shareholders' expense and demanding...To view the full article, register now.
Already a subscriber? Click here to view full article